Search results
Taking a look at what insiders are doing to gauge the PTC Therapeutics Inc
Knox Daily· 14 hours agoEarlier on October 27, 2023, Citigroup downgraded its rating. Their new recommendation was “a Sell” for PTCT stock which previously was a “a Neutral”. Analyzing ...
PTC Therapeutics (NASDAQ:PTCT) Raised to “Equal Weight” at Morgan Stanley
ETF DAILY NEWS· 17 hours agoMorgan Stanley upgraded shares of PTC Therapeutics (NASDAQ:PTCT – Free Report) from an underweight rating to an equal weight rating in a report released on Monday, Benzinga ...
Handelsbanken Fonder AB Buys 3,400 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT)
ETF DAILY NEWS· 7 hours agoHandelsbanken Fonder AB boosted its stake in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 25.6% during the 4th quarter, according to its most recent disclosure ...
PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
Investor's Business Daily· 1 day agoDecades of market research reveals that the best-performing stocks typically have an RS Rating north...
Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT)...
Simply Wall St. via Yahoo Finance· 4 days agoPTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders will have a reason to smile today, with the...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoPTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript April 25, 2024 PTC...
Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics
Zacks via Yahoo Finance· 7 days agoAlthough the revenue and EPS for PTC Therapeutics (PTCT) give a sense of how its business performed...
PTC Therapeutics: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 7 days agoFive analysts surveyed by Zacks expected $160.3 million. PTC Therapeutics expects full-year revenue in the range of $600 million to $680 million. _____ This story was generated by Automated ...
